Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

GSK Stock News Today (Dec. 23, 2025): Buyback Update, Director Buying, US Drug-Pricing Deal, and FDA Wins — What Analysts Forecast Next

GSK Stock News Today (Dec. 23, 2025): Buyback Update, Director Buying, US Drug-Pricing Deal, and FDA Wins — What Analysts Forecast Next

GSK plc stock is ending 2025 with a dense cluster of catalysts—some bullish, some complicated, and all very “big pharma in an election-year policy blender.” Early Tuesday (Dec. 23, 2025), GSK’s ADR (NYSE: GSK) traded around $48.59, essentially flat on
Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

London-listed Anglo American plc is ending 2025 with its investment story compressed into two big levers: a once-in-a-generation copper market and a once-in-a-generation corporate reshuffle. On December 23, those levers are both moving. The company has published provisional 2026 dividend
1 284 285 286 287 288 605
Go toTop